The results showed that reduced expression of stromal Cav‐1 was associated with a poor PDAC prognosis and correlated with a PDAC stroma‐tumour cell metabolism shift, with stroma cells tending to undergo glycolysis and tumour cells tending to undergo OXPHOS. This evidence concerns the gene CAV1 and neoplasm.